BioNTech SE (BNTX) Reports Q1 EPS of EUR14.24, Reiterates FY22 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to BioNTech SE (BNTX) Reports Q1 EPS of EUR14.24, Reiterates FY22 Guidance

BioNTech Announces First Quarter Financial Results and Corporate Update

May 9, 2022 6:01 AM EDT

First quarter revenues of 6.4 billion1, net income of 3.7 billion and fully diluted earnings per share of 14.24 ($15.972)Reiterates BioNTech COVID-19 2022 vaccine revenue guidance of 13 billion to 17 billionFirst-in-class CAR-T program targeting CLDN-6 (BNT211) in solid tumors showed manageable safety profile and signs of clinical activity; preliminary Phase 1/2 data presented at AACR Annual Meeting 2022Continued pipeline expansion to 16 clinical stage oncology programs in 20 ongoing clinical trials 

Conference call and webcast scheduled for May 9, 2022, at 8:00 am ET (2:00 pm CET)

... More